Send us a text
Dr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.
Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck’s three business sectors. She also spearheaded the company’s efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.
Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:
• As Biotechnology Lead of a synthetic biology innovation project,
• As Senior Manager, responsible for creating strategic alignment and building high-performing teams, and
• As Associate Director, focusing on sourcing innovative ideas to generate new business opportunities.
Dr. Siragusa earned her Ph.D. in Biology from the University of Tuebingen, Germany, and conducted research in Europe and the USA, including at Yale University, before joining Merck KGaA, Darmstadt, Germany in 2016.
In 2024, she completed an MBA in Digital Transformation Management with a focus on Digital Leadership at Goethe Business School, Frankfurt, Germany.
Dr. Siragusa is also the lead author of the recently published book, Bioconvergence Revolution: Challenges and Opportunities in Research Productivity. You can find it here:
https://link.springer.com/book/10.1007/978-3-031-61593-1
Home Page Merck KGaA Darmstadt, Germany - https://www.emdgroup.com/en
#NinaSiragusa #EMDGroup #MerckKGaADarmstadtGermany #Bioconvergence #Ethics #Collaboration #Fungi #NaturalProducts #Biomimicry #AI #DrugDiscovery #Bioremediation #TranslationalMedicine #SmartManufacturing #DigitalTwins #Supermind #MIT #ResearchFunding #Israel #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast
Support the show
View all episodes
By Ira Pastor
5
22 ratings
Send us a text
Dr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.
Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck’s three business sectors. She also spearheaded the company’s efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.
Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:
• As Biotechnology Lead of a synthetic biology innovation project,
• As Senior Manager, responsible for creating strategic alignment and building high-performing teams, and
• As Associate Director, focusing on sourcing innovative ideas to generate new business opportunities.
Dr. Siragusa earned her Ph.D. in Biology from the University of Tuebingen, Germany, and conducted research in Europe and the USA, including at Yale University, before joining Merck KGaA, Darmstadt, Germany in 2016.
In 2024, she completed an MBA in Digital Transformation Management with a focus on Digital Leadership at Goethe Business School, Frankfurt, Germany.
Dr. Siragusa is also the lead author of the recently published book, Bioconvergence Revolution: Challenges and Opportunities in Research Productivity. You can find it here:
https://link.springer.com/book/10.1007/978-3-031-61593-1
Home Page Merck KGaA Darmstadt, Germany - https://www.emdgroup.com/en
#NinaSiragusa #EMDGroup #MerckKGaADarmstadtGermany #Bioconvergence #Ethics #Collaboration #Fungi #NaturalProducts #Biomimicry #AI #DrugDiscovery #Bioremediation #TranslationalMedicine #SmartManufacturing #DigitalTwins #Supermind #MIT #ResearchFunding #Israel #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast
Support the show
43,647 Listeners
2,057 Listeners
1,086 Listeners
17,023 Listeners
15 Listeners